Exchanges NASDAQ

  • New Bull Market Could Be Costly

    The expense of all-time market highs could come at a price. Are stocks on the verge of a pullback? Chris Bertelsen, Global Financial Private Capital; and Tim Holland, Partner, TAMRO Capital, weigh in on whether it's time for investors to "take some money off the table."

  • Big Movers on the Nasdaq

    CNBC's Seema Mody reports on the biggest movers on the Nasdaq today.

  • Nasdaq Midday Update

    CNBC's Seema Mody provides an update on what's moving the tech sector today.

  • Nasdaq Buys BGC's eSpeed Platform

    Howard Lutnick, BGC Partners CEO, explains why he is selling the company's electronic Treasury trading platform to the Nasdaq OMX Group for nearly $1.3 billion.

  • Nasdaq

    Nasdaq OMX's $750 million deal to buy the eSpeed platform for trading U.S. Treasurys was a bet the government will keep maxing out the nation's credit card, CEO Robert Greifeld told CNBC.

  • Nasdaq's Treasury Trading Expansion

    Robert Greifeld, Nasdaq OMX CEO, discusses the details of a deal to acquire eSpeed from BGC Partners for $1.23 billion in cash and stock.

  • Nasdaq OMX Acquires eSpeed For $750 Million

    CNBC's Seema Mody reports the NASDAQ OMX has acquired the eSpeed trading platform from BGC Partners for $750 million.

  • eBay Upgraded to Buy

    CNBC's Seema Mody reports on the big movers on the Nasdaq, including eBay after the stock was upgraded by Canaccord Genuity.

  • Tech Wars: Apple Down 17% YTD

    CNBC's Seema Mody reports on the big movers on the Nasdaq. Apple has dropped to the second holding in Fidelity Contrafund behind Google.

  • The "Mad Money" host highlights a pharma stock that he thinks might produce considerable gains.

  • Two Big Bulls Target S&P

    Barry Bannister, Stifel Nicolaus; and Tony Dwyer, Canaccord Genuity, explain why they both raised their target on the S&P 500, and weigh in on where investors should be putting their money.

  • Mixed Session For Generic Drugmakers

    CNBC's Seema Mody reports the latest from the Nasdaq: Drug makers Actavis and AstraZeneca reach an agreement to launch a Crestor generic in 2016.

  • Nasdaq Moving Higher

    CNBC's Seema Mody has the latest from the Nasdaq, saying Apple is breaking its 50-day moving average.

  • Tech Stocks Rise Ahead of the Fed

    A look at tech stocks ahead of the Fed's statement on the U.S. economy, with CNBC's Seema Mody.

  • Nasdaq Latest: Cyprus, Apple's Cash & More

    CNBC's Seema Mody reports the Cyprus bailout is weighing on risk-on sectors.

  • Apple Shares Upgraded to Buy

    BTIG Capital upgraded Apple to a buy, and Amazon was downgraded to neutral at JPMorgan, reports CNBC's Seema Mody.

  • Top 2013 Disruptors Convene at the Nasdaq

    Shervin Pishevar, Menlo Ventures Advisors, discusses how innovation will impact the next decade, as top tech business leaders gathering today at the "F.ounder's" conference in New York.

  • Apple Bear Trade Over?

    If there is a pullback in the markets, will this be a catalyst for Apple's stock? CNBC's Seema Mody has the details.

  • 5% Market Correction Ideal Entry Point For Investors: Pro

    Vasu Menon, Vice President of Wealth Management Singapore at OCBC Bank, warns that volatility should be expected going forward and a correction of 5% would be ideal entry point into the markets.

  • Battle In Tech Continues

    Google has overtaken Apple as the top U.S. mutual fund holding, reports CNBC's Seema Mody.